Amgen Value & Access Sr. Manager (New Product Development Market Access Oncology (m/f) in Munich, Germany

To enable the development of robust commercial and medical strategies that are closer to customers and fit key markets, Amgen introduced the 'Archetype" Country concept. Six Countries including Germany are designated as Archetypes for their diversity across key market dimensions (e.g. market access system, medical practice, competitive landscape). Direct participation from the Archetype Countries will provide customer insights and ongoing input to the Global IBPT (Insights and Brand Planning Team) and EGT (Evidence Generation Team). The Jobholder is responsible for new pipeline products in the Therapeutic Area (TA) Hematology/Oncology.


Represent Germany as an Archetype Country at the Global Product Team (IBPT) by providing input and insights into the access processes, payer regulations and policy environment with regards to oncology pipeline products.

Provide in depths local access and reimbursement insights on:

  • Payer, provider and payer channels and channel characteristics regarding reimbursement processes as well as national, regional and local regulations

  • The magnitude of the opportunity in each segment

  • The approach and pathway that each payer segment takes to determine funding e.g. budget impact, cost effectiveness, cost minimization, private out of pocket

  • The drivers and barriers to market access from state, federal, institutions and patients

  • The evolution of the reimbursement/funding system in the different segments and what the environment will evolve to at launch and beyond

  • The treatment options and directional assessment on product price bands

  • The value evidence and input to the clinical study program with regards to endpoints and comparators that are required to support optimal product access at launch sequence and meet the requests of HTA body/authorities

  • The local Policy environment, key stakeholders and pending changes to policy/legislation, budget that will impact access at launch

  • The contracting environment on a national and regional level and how its evolution will impact prescribing choice by physicians

  • Competitor positioning with focus on pricing and contracting in the HC environment

  • The role of patient advocates and how it is evolving

External engagement:

  • Engage with relevant reimbursement/funding authorities to understand current landscape and anticipate future changes

Communication and collaboration:

  • Clear, effective communication to the IBPT

  • Collaborate closely with functional country New Product Development Lead (NPDL) colleagues of the medical and marketing department

  • Update local affiliate and key stakeholders on key issues and opportunities (e.g. pipeline planning and evolution)


  • Development of local access/reimbursement plan addressing how to gather the insights to inform product Team strategy

The job holder reports to the Executive Director Value, Access & Policy Germany with a dotted-line reporting to the Global Team.


Skills, knowledge & experience:

    • Bachelor's degree or equivalent combination of education and experience, MBA or other advanced degree preferred
    • Ideally a minimum of 4 years relevant in-country pharma/biotech marketing experience and 2 or more years of strategic/upstream marketing experience, including development of global/regional/local brand plans
    • Experience in successfully launching multiple products in country (AMNOG experience) a plus
    • In depth knowledge of the payer, government environment including reimbursement, managed entry agreements, pricing, contracting, value drivers, formulary management, HTA policy, and government affairs/policy/advocacy
    • Familiarity with global value dossier (GVD) activities
    • Direct national and regional payer experience and/or experience in product Commercialization
    • Ability to review clinical and health economics literature, including disease state information, clinical trial design and results, and pharmacoeconomic studies to understand implications for payers
    • Understanding of what needs to be differentiated in the access strategy for the product to be successful
    • Significant hands-on experience in working and leading within a matrix organization
    • Fluency in German and English, both in oral and written communication
    • Computer Skills (MS Office programs)

Preferred Qualifications:

    • Global and regional work experience in multiple geographies
    • Direct access knowledge and experience working with delivery devices, including gathering and translating customer needs into device branding strategies
    • Specific Experience and expertise in one or more of the relevant therapeutic areas is beneficial

Key Competencies:

    • Demonstrated experience as broad strategic thinker and in being able to influence stakeholders across a global organization
    • Demonstrated ability to assimilate and integrate complex information across functional areas (e.g. Marketing, Value, Access & Policy, Clinical) into holistic go-to-market strategy
    • Self-starting and self-motivating character with strong interpersonal/communication skills
    • Delivering results through effective peer and team leadership where appropriate
  • *Due to time shifts around the world a very high flexibility is key

  • *High level (and willingness) of travel activities is mandatory

For further questions please contact:

Phyllis Kiefer (Human Resources)

phone: 089/ 4 90 96-1164